Md Habban Akhter

About

Md. Habban Akhter has graduated and master in pharmacy (Pharmaceutics) from Jamia Hamdard, New Delhi and completed doctoral program in 2016. He had qualified GATE exam conducted by IIT, Kanpur, Govt. of India, percentile score 97.04 in 2007. He had honored with JRF by UGC, SRF by DST-SERB Govt. of India. His work of interest is novel drug delivery system, nanotechnology- based work formulation design, engineered nanoparticles targeting approach in cancer therapy and nanomedicine. He published several research and review papers in high impact journal of repute. He has attained and presented many papers at national and international conferences/seminars/symposia. Currently, he is working as Assistant Professor at DIT University, Dehradun, India.

Employment

• Faculty of Pharmacy, DIT University
  2017 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (55)

• Formulation, Characterization, and Biological Assessment of Embelin-Loaded Glycerosomes
  ASSAY and Drug Development Technologies 2026 DOI: 10.1177/1540658X261449845
  +Save
• pH- and Temperature-Responsive Hydrogel Composite Dual-Loaded with Neomycin and Bromelain for Enhanced Diabetic Wound Repair
  Journal of Cluster Science 2026 DOI: 10.1007/s10876-026-03017-y
  +Save
• Novel approaches to combat multidrug resistance bacterial infections
  Next Research 2026 DOI: 10.1016/j.nexres.2026.101317
  +Save
• SynerGel: Ciprofloxacin–Borneol Dual‑Loaded Stimuli-Triggered In-Situ Gel for Precision Ocular Delivery in Conjunctivitis
  Journal of Pharmaceutical Innovation 2026 DOI: 10.1007/s12247-026-10761-1
  +Save
• Validation of an Reverse phase high performance liquid chromatography Method for In Vitro Quantification and Degradation Analysis of Naphthol AS-E Phosphate in Bulk Drugs and Nanoparticles
  ASSAY and Drug Development Technologies 2025 DOI: 10.1177/1540658x251377978
  +Save
• Integrating computational insights in gold nanoparticle-mediated drug delivery: enhancing efficacy and precision
  Frontiers in Medical Technology 2025 DOI: 10.3389/fmedt.2025.1528826
  +Save
• β-Cyclodextrin/PVP-Stabilized Nanocrystal Gel for Dual Release of Rutin and Thymoquinone for Wound Healing
  Journal of Cluster Science 2025 DOI: 10.1007/s10876-024-02735-5
  +Save
• Mesalamine loaded ethyl cellulose nanoparticles: optimization and in vivo evaluation of antioxidant potential in ulcerative colitis
  Biomedical Materials 2025 DOI: 10.1088/1748-605X/ad920e
  +Save
• A Novel Mesalamine Loaded Hybrid Nanoparticle-in-Microparticle for Colon Targeting: In-vitro and In-vivo Investigations
  Journal of Pharmaceutical Innovation 2024 DOI: 10.1007/s12247-024-09882-2
  +Save
• Adjuvant Novel Nanocarrier-Based Targeted Therapy for Lung Cancer
  Molecules 2024 DOI: 10.3390/molecules29051076
  +Save